| name | endo-statin-contraindication-pregnancy |
| description | Recommends against using statins in women who are pregnant or trying to become pregnant. Trigger phrases include "Female patient of childbearing potential needing lipid therapy", "Assessing medication safety in pregnancy", "Considering statin for lipid disorder in pregnancy". |
Avoid statin use in pregnancy or when trying to become pregnant
STEP 1 — Gather Information
Assess pregnancy status, intention to conceive, last menstrual period, and contraceptive use in females of childbearing potential presenting for lipid therapy.
STEP 2 — Rule In / Rule Out
Is the patient pregnant or actively trying to become pregnant? If yes, proceed to Step 4 (avoid statin); if no, proceed to Step 3.
STEP 3 — Classify or Stratify
Evaluate lipid-lowering indication per guideline (e.g., LDL‑C >70 mg/dL, ASCVD risk, risk‑enhancing factors) to determine if statin therapy is otherwise indicated.
STEP 4 — Decide
If pregnant or trying to conceive, do not initiate statin; emphasize lifestyle modification and postpone pharmacologic lipid therapy until after pregnancy. If not pregnant and statin is indicated, initiate appropriate statin therapy.
Clinical Guardrails / Mimics / Pitfalls
Do not rely on statins for lipid control in pregnancy due to teratogenic risk (FDA Category X); avoid in lactation unless benefit outweighs risk; do not mistake elevated lipids in pregnancy as requiring statin therapy.
Concrete Clinical Example
A 32‑year‑old woman with PCOS and LDL‑C 160 mg/dL who is planning pregnancy; statin is withheld, lifestyle changes (diet, exercise) are started, and lipid therapy is reconsidered postpartum.
Source: Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, doi:10.1210/clinem/dgaa674
